IGF1R and sarcoma: The IGF‐1R/mTOR pathway is frequently activated in sarcomas and other solid tumors, so it is considered an attractive target for Osteosarcoma (OS) and Ewing sarcoma (ES) since it represents the aggregation of multiple chemical and mechanical signaling mechanisms.